Compare Alkermes plc Ordinary Shares (ALKS) vs Salesforce Inc (CRM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Alkermes plc Ordinary Shares vs Salesforce Inc — how do they compare? Alkermes plc Ordinary Shares trades at $45.25 (market cap $7.52B), while Salesforce Inc trades at $228.24 (market cap $182.87B). The key difference: Salesforce Inc is far larger — about 24.3× Alkermes plc Ordinary Shares's market cap, and Salesforce Inc pays a 0.79% dividend while Alkermes plc Ordinary Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold Alkermes plc Ordinary Shares for 12 Days and Salesforce Inc for 89 Days on average.
| ALKS | CRM | |
|---|---|---|
Market Cap | $7.52B | $182.87B |
Volume | 2,162,296 | 6,606,939 |
Sector | Health | Technology |
52-Week High | $55.22 | $266.23 |
52-Week Low | $27.20 | $150.12 |
Typical Hold Time | 12 Days | 89 Days |
Enterprise Value | $8.44B | $213.21B |
Dividend Yield | — | 0.79% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Salesforce (CRM) trades at $227.11, up 0.41% on the day, but faces a bearish technical signal with key resistance at $228. The company demonstrates strong fundamentals with a 77.28% gross margin and consistent earnings beats, including a Q2 2026 EPS of $5.90 versus $3.27 expected. Revenue growth is robust, reaching $37.90B in 2025, with net income climbing to $6.20B. However, recent news highlights sector-wide pressure on software stocks due to AI advancements and macroeconomic concerns.
The outlook remains positive based on strong profitability and analyst consensus, with a $274.18 price target implying significant upside. Key risks include competitive threats from AI disruption and market volatility, but the company's solid cash flow and institutional support provide a foundation for recovery. Investment appeal is high for growth-oriented investors seeking exposure to enterprise software with improving margins.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Alkermes plc Ordinary Shares
Alkermes plc is a biopharmaceutical company that develops and markets medicines for psychiatric and neurological disorders, including schizophrenia, bipolar I disorder, alcohol and opioid dependence, and narcolepsy, with marketed products such as Vivitrol, Aristada, Lybalvi, and Lumryz.
Read more on ALKS →About Salesforce Inc
Salesforce Inc provides enterprise cloud computing solutions. The company offers customer relationship management technology that brings companies and customers together. Its Customer 360 platform helps the group to deliver a single source of truth, connecting customer data across systems, apps, and devices to help companies sell, service, market, and conduct commerce. It also offers Service Cloud for customer support, Marketing Cloud for digital marketing campaigns, Commerce Cloud as an e-commerce engine, the Salesforce Platform, which allows enterprises to build applications, and other solutions, such as MuleSoft for data integration.
Read more on CRM →
